Skip to main content
Log in

Polyvalent immunoglobulins for prophylaxis of bacterial infections in patients following multiple trauma

A randomized, placebo-controlled study

  • Original Articles
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

One hundred and fifty severely injured patients requiring long-term artificial ventilation were evaluated in a prospective, randomized, double blind study comparing the prophylactic effect of an intravenous immunoglobulin (Sandoglobulin; IGIV) against nosocomial infections with a placebo preparation. The groups were comparable in age, sex, injury pattern, and severity of the trauma. Seventy-six patients received 12 g of Sandoglobulin as a 3% solution on day 0, day 5 and day 12, i.e. a total of 36g. Sandoglobulin significantly reduced the incidence of pneumonia (28 cases in the IGIV group, 43 cases in the placebo group, p=0.0111). This resulted in a reduced therapeutic use of antibiotics. For the occurrence of sepsis (IGIV: 14 cases; placebo 19 cases) and other infections (IGIV: 11 cases; placebo: 10 cases) no significant differences were found. No side effects of the administration of IGIV were observed. IGIV prophylaxis neither reduced the overall death rate nor those deaths caused by infection. On day 5 after administration of the first 12 g of IGIV, the IgG serum concentrations were significantly higher in the Sandoglobulin group (8.41±1.96 mg/ml and 7.42±2.25 mg/ml respectively, p>0.001) whereas later serum samples showed no significant differences.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ammann AJ, Ashman FR, Buckley RH, Hardie WR, Krautmann HJ, Nelson J, Ochs H, Striehm ER, Tiller Th, Wara DW, Wedgwood R (1982) Use of intravenous gammaglobulin in antibody immunodeficiency: Results of a multicenter controlled trial. Clin Immunol Immunopathol 22:60

    Google Scholar 

  2. Barandun S, Koblet H, Aebersold J (1963) Exsudative Enteropathie. Schweiz Med Wochenschr 93:1074

    Google Scholar 

  3. Barandun S, Skvaril F, Morell A (1973) Prophylaxis and treatment of diseases by means of immunoglobulins. Monogr Allergy 9:39

    Google Scholar 

  4. Barandun S, Morell A, Skvaril F (1979) Clinical experiences with immunoglobulin for intravenous use. In: Alving BM, Finlavson JS (eds) Immunoglobulins: characteristics and uses of intravenous preparations. U.S. Department of Health and Human Services, p 31

  5. Barandun S, Morell A (1981) Adverse reactions to immunoglobulin preparations. In: Nydegger UE (ed) Immunotherapy. Academic Press, London, p 223

    Google Scholar 

  6. Baker SP, O'Neill B, Haddon W, Long WG (1974) The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma 14:187

    Google Scholar 

  7. Berghem L, Lahnborg C, Jarstrand C (1979) Role of phagocytic cells in host defence in relation to trauma—a brief review. Acta Chir Scand Suppl 489:231

    Google Scholar 

  8. Bryant LR, Trinkle JK, Mobin-Uddin K, Baker J, Griffen WO (1972) Bacterial colonization profile with tracheal intubation and mechanical ventilation. Arch Arug 104:647

    Google Scholar 

  9. Bussel J, Lalezari P, Hilgartner M, Partin J, Fikrig S, O'Malley J, Barandun S (1983) Reversal of neutropenia with intravenous gammaglobulin in autoimmune neutropenia of infancy. Blood 62:398

    Google Scholar 

  10. Centers for Disease Control, Atlanta, Georgia (1978) Outline for surveillance and control of nosocomial infections.

  11. Cunningham-Rundles Ch, Siegal FP, Smithwick EM Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease (submitted for publication)

  12. Daniele RP (1980) Immuno defenses of the lung. In: Fishman AP (ed) Pulmonary disease and disorders. McGraw-Hill, New York, p 624

    Google Scholar 

  13. Daschner FD (1978) Antibiotikaprophylaxe in der Intensivmedizin. Helv Chir Acta 45:475

    Google Scholar 

  14. Daschner FD, Frey P, Wolff G, Baumann PC, Suter P (1982) Nosocomial infections in intensive care wards: a multicenter prospective study. Intensive Care Med 8:5

    Google Scholar 

  15. Duswald KW, Müller K, Seifert J, Ring J (1980) Wirksamkeit von i. v. Gammaglobulin gegen bakterielle Infektionen chirurgischer Patienten. Ergebnisse einer kontrollierten, randomisierten klinischen Studie. Münch Med Wochenschr 122:832

    Google Scholar 

  16. Garibaldi RA, Britt MR, Coleman M, Reading J, Pace N (1981) Risk factors for postoperative pneumonia. Am J Med 70:677

    Google Scholar 

  17. Glinz W (1980) Die sekundäre bakterielle Infektion. In: Wolff G, Suter PM (eds) Akutes Atemnotsyndrom des Erwachsenen. Springer, Berlin Heidelberg New York, p 95

    Google Scholar 

  18. Green GM, Jakob GJ, Low RB, Davis GS (1977) Defense mechanisms of the respiratory membrane. Am Rev Respir Dis 115:479

    Google Scholar 

  19. Hooton ThM, Haley RW, Culver DH, White JW, Morgan WM (1981) The joint associations of multiple risk factors with the occurrence of nosocomial infection. Am J Med 70:960

    Google Scholar 

  20. Howard RJ, Simmons RL (1974) Acquired immunologic deficiencies after trauma and surgical procedures. Surg Gynaecol Obst 139:771

    Google Scholar 

  21. Imbach P, Barandun S, d'Appuzzo V, Baumgartner C, Hirt A, Morell A, Rossi E, Schöni M, Vest M, Wagner HP (1981) High dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1:1228

    Google Scholar 

  22. LaForce FM (1981) Hospital-acquired gram-negative rod pneumonias: An overview. Am J Med 70:664

    Google Scholar 

  23. Ledingham I McA, Watt I (1983) Influence of sedation on mortality in critically ill multiple trauma patients. Lancet 1:1270

    Google Scholar 

  24. Levy AL, Waldmann ThA (1970) The effect of hydrocortisone on immunoglobulin metabolism. J Clin Invest 49:1679

    Google Scholar 

  25. McCabe WR, Finland M (eds) (1977) Contemporary standards for antimicrobial usage. In: Principles and techniques of human research and therapeutics. Futura, Mount Kisco, p 13

    Google Scholar 

  26. Morell A, Schürr B, Ryser D, Hofer F, Skvaril F, Barandun S (1980) In vivo behaviour of gammaglobulin preparations. Vox Sang 38:272

    Google Scholar 

  27. Osterholm MT, Bowman RJ, Chopek MW, McCullough JJ, Korlath JA, Polesky HF (1985) Screening donated blood and plasma for HTLV-III antibody. New Engl J Med 312:1185

    Google Scholar 

  28. Pollack M (1983) Antibody activity against Pseudomonas aeruginosa in immune globulins prepared for intravenous use in humans. J Infect Dis 148:1090

    Google Scholar 

  29. Riva G, Barandun S, Koblet D, Nusslé D, Witschi HP (1964) Proteinverlierende Gastroenteropathien: Klinik und Pathophysiologie. In: Peeters H (ed) Protides of the biological fluids. II. Elsevier, Amsterdam, p 168

    Google Scholar 

  30. Römer J, Morgenthaler JJ, Scherz R, Skvaril F (1982) Characterization of various immunoglobulin preparations for intravenous application. I. Protein composition and antibody content. Vox Sang 42:62

    Google Scholar 

  31. Sleigh JD, Dick HM (1983) Problems of defective immunity: The diminished immune response. In: Wilson G, Miles A, Parker MT (eds) Principles of bacteriology, virology and immunity. Edward Arnold, London, p 402

    Google Scholar 

  32. Stevens RM, Teres D, Skillman JJ, Feingold DS (1974) Pneumonia in an intensive care unit. Arch Intern Med 134:106

    Google Scholar 

  33. von Muralt G, Sidiropoulos D (1981) Intravenous Ig substitution therapy in the treatment of septicemia in preterm neonates. In: Nydegger UE (ed) Immunochemotherapy. Academic Press, London, p 313

    Google Scholar 

  34. Wochner RD (1970) Hypercatabolism of normal IgG; an unexplained immunoglobulin abnormality in the connective tissue diseases. J Clin Invest 48:454

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Glinz, W., Grob, P.J., Nydegger, U.E. et al. Polyvalent immunoglobulins for prophylaxis of bacterial infections in patients following multiple trauma. Intensive Care Med 11, 288–294 (1985). https://doi.org/10.1007/BF00273538

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00273538

Key words

Navigation